We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Cumulative incidence of noncommunicable diseases was ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A risk prediction model assesses seven variables to ...

In a recent study published in the journal Nutrients, researchers conducted a systematic review of human clinical trials that examined the administration of oral probiotics to improve gut microflora ...

The HOME (Hyperinsulinemia: the Outcome of its Metabolic Effects) trial was a randomized, placebo-controlled, multicenter study designed to test the hypothesis that metformin (compared with placebo) ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...

Dementia risk in type 2 diabetes varies by treatment, with some metformin-based combination therapies offering greater protection.

Glucose lowering is greater when metformin is given before rather than with enteral glucose; this is also linked to greater GLP-1 response. HealthDay News — Glucose lowering by metformin is greater ...

Potential fathers with type 2 diabetes can be reassured that taking the drug metformin is not associated with birth defects in their offspring, concludes a large study of more than 3 million ...